Literature DB >> 25407929

Intrathymic Tfh/B Cells Interaction Leads to Ectopic GCs Formation and Anti-AChR Antibody Production: Central Role in Triggering MG Occurrence.

Xiaoyan Zhang1,2,3, Shasha Liu1,2, Ting Chang1, Jiang Xu1, Chunmei Zhang2, Feng Tian4, Yuanjie Sun2, Chaojun Song2, Wei Yi5, Hong Lin1, Zhuyi Li6, Kun Yang7.   

Abstract

Myasthenia gravis is a typical acetylcholine receptor (AChR) antibody-mediated autoimmune disease in which thymus frequently presents follicular hyperplasia or thymoma. It is now widely accepted that the thymus is probably the site of AChR autosensitization and autoantibody production. However, the exact mechanism that triggers intrathymic AChR antibody production is still unknown. T follicular helper cells, recently identified responsible for B cell maturation and antibody production in the secondary lymphoid organs, were involved in many autoimmune diseases. Newly studies found T follicular helper (Tfh) cells increased in the peripheral blood of myasthenia gravis (MG). Whether it appears in the thymus of MG and its role in the intrathymic B cells help and autoantibody production is unclear. Therefore, this study aims to determine in more detail whether Tfh/B cell interaction exist in MG thymus and to address its role in the ectopic germinal centers (GCs) formation and AChR antibody production. We observed the frequency of Tfh cells and its associated transcription factor Bcl-6, key cytokine IL-21 enhanced both in the thymocytes and peripheral blood mononuclear cells (PBMCs) of MG patients. In parallel, we also showed increased B cells and autoantibody titers in MG peripheral blood and thymus. Confocal microscope results demonstrated Tfh and B cells co-localized within the ectopic GCs in MG thymus, suggesting putative existence of Tfh/B cells interaction. In vitro studies further showed dynamic behavior of Tfh/B cells interaction and Tfh cells induced autoantibody secretion might through its effector cytokine IL-21. Altogether, our data demonstrated that intrathymic Tfh/B cells interaction played a key role in thymic ectopic GCs formation and anti-AChR antibody production, which might trigger MG occurrence.

Entities:  

Keywords:  Anti-acetylcholine receptor antibody; Follicular helper T cells; Germinal centers; Myasthenia gravis; Thymus

Mesh:

Substances:

Year:  2014        PMID: 25407929     DOI: 10.1007/s12035-014-8985-1

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  37 in total

Review 1.  The elusive identity of T follicular helper cells.

Authors:  Di Yu; Carola G Vinuesa
Journal:  Trends Immunol       Date:  2010-08-31       Impact factor: 16.687

Review 2.  The good, the bad and the ugly - TFH cells in human health and disease.

Authors:  Stuart G Tangye; Cindy S Ma; Robert Brink; Elissa K Deenick
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

3.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

4.  Th1 epitope repertoire on the alpha subunit of human muscle acetylcholine receptor in myasthenia gravis.

Authors:  Z Y Wang; D K Okita; J Howard; B M Conti-Fine
Journal:  Neurology       Date:  1997-06       Impact factor: 9.910

5.  Altered expression of chemokine receptor CXCR5 on T cells of myasthenia gravis patients.

Authors:  Ryuji Saito; Hiroshi Onodera; Hideaki Tago; Yasushi Suzuki; Masayuki Shimizu; Yuji Matsumura; Takashi Kondo; Yasuto Itoyama
Journal:  J Neuroimmunol       Date:  2005-10-07       Impact factor: 3.478

Review 6.  The many faces of Th17 cells.

Authors:  Anneli Peters; Youjin Lee; Vijay K Kuchroo
Journal:  Curr Opin Immunol       Date:  2011-09-06       Impact factor: 7.486

7.  Follicular helper T cells: new insights into mechanisms of autoimmune diseases.

Authors:  Xin Zhang; Sharon Ing; Austin Fraser; Minzi Chen; Omar Khan; Jerald Zakem; William Davis; Robert Quinet
Journal:  Ochsner J       Date:  2013

Review 8.  Lymphoid neogenesis in chronic inflammatory diseases.

Authors:  Francesca Aloisi; Ricardo Pujol-Borrell
Journal:  Nat Rev Immunol       Date:  2006-03       Impact factor: 53.106

9.  The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis.

Authors:  Amel Meraouna; Geraldine Cizeron-Clairac; Rozen Le Panse; Jacky Bismuth; Frederique Truffault; Chantal Tallaksen; Sonia Berrih-Aknin
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

10.  Acetylcholine receptor-reactive T cells in myasthenia gravis: evidence for the involvement of different subpopulations of T helper cells.

Authors:  Q Yi; R Ahlberg; R Pirskanen; A K Lefvert
Journal:  J Neuroimmunol       Date:  1994-03       Impact factor: 3.478

View more
  19 in total

Review 1.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

2.  High frequencies of circulating Tfh-Th17 cells in myasthenia gravis patients.

Authors:  Yongxiang Yang; Min Zhang; Yuqin Ye; Shan Ma; Lingling Fan; Zhuyi Li
Journal:  Neurol Sci       Date:  2017-06-03       Impact factor: 3.307

Review 3.  B cells in the pathophysiology of myasthenia gravis.

Authors:  John S Yi; Jeffrey T Guptill; Panos Stathopoulos; Richard J Nowak; Kevin C O'Connor
Journal:  Muscle Nerve       Date:  2017-09-30       Impact factor: 3.217

Review 4.  Roles of cytokines and T cells in the pathogenesis of myasthenia gravis.

Authors:  A Uzawa; S Kuwabara; S Suzuki; T Imai; H Murai; Y Ozawa; M Yasuda; Y Nagane; K Utsugisawa
Journal:  Clin Exp Immunol       Date:  2020-12-03       Impact factor: 5.732

Review 5.  Tertiary lymphoid organs in systemic autoimmune diseases:  pathogenic or protective?

Authors:  William D Shipman; Dragos C Dasoveanu; Theresa T Lu
Journal:  F1000Res       Date:  2017-02-28

6.  Increased Circulating T Follicular Helper Cells Are Inhibited by Rituximab in Neuromyelitis Optica Spectrum Disorder.

Authors:  Cong Zhao; Hong-Zeng Li; Dai-Di Zhao; Chao Ma; Fang Wu; Ya-Nan Bai; Min Zhang; Zhu-Yi Li; Jun Guo
Journal:  Front Neurol       Date:  2017-03-15       Impact factor: 4.003

Review 7.  Follicular Helper T Cells in Systemic Lupus Erythematosus.

Authors:  Sun Jung Kim; Kyungwoo Lee; Betty Diamond
Journal:  Front Immunol       Date:  2018-08-03       Impact factor: 7.561

8.  CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS.

Authors:  Merve Çebi; Hacer Durmus; Fikret Aysal; Berker Özkan; Gizem Engin Gül; Arman Çakar; Mehmet Hocaoglu; Metin Mercan; Sibel P Yentür; Melih Tütüncü; Vildan Yayla; Onur Akan; Öner Dogan; Yeşim Parman; Güher Saruhan-Direskeneli
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

9.  T Follicular Helper-Like Cells Are Involved in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.

Authors:  Jun Guo; Cong Zhao; Fang Wu; Liang Tao; Chunmei Zhang; Daidi Zhao; Shuya Yang; Dongbo Jiang; Jing Wang; Yuanjie Sun; Zhuyi Li; Hongzeng Li; Kun Yang
Journal:  Front Immunol       Date:  2018-05-07       Impact factor: 7.561

10.  Use of Toll-Like Receptor Agonists to Induce Ectopic Lymphoid Structures in Myasthenia Gravis Mouse Models.

Authors:  Marieke Robinet; Bérengère Villeret; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Front Immunol       Date:  2017-08-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.